11,104 Rocket Lab Corporation $RKLB Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lessened its stake in Rocket Lab Corporation (NASDAQ:RKLB) by 20.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 42,790 shares of the rocket manufacturer’s stock after selling 11,104 shares during the period. Oppenheimer & Co. Inc.’s holdings in Rocket Lab were worth $2,982,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Park Avenue Securities LLC increased its position in Rocket Lab by 37.4% during the 3rd quarter. Park Avenue Securities LLC now owns 31,469 shares of the rocket manufacturer’s stock valued at $2,193,000 after purchasing an additional 8,567 shares during the period. Verdence Capital Advisors LLC lifted its position in shares of Rocket Lab by 9.8% in the 3rd quarter. Verdence Capital Advisors LLC now owns 2,912 shares of the rocket manufacturer’s stock worth $203,000 after purchasing an additional 259 shares during the period. Flagship Harbor Advisors LLC lifted its position in shares of Rocket Lab by 45.2% in the 3rd quarter. Flagship Harbor Advisors LLC now owns 8,615 shares of the rocket manufacturer’s stock worth $600,000 after purchasing an additional 2,682 shares during the period. CPR Investments Inc. acquired a new position in shares of Rocket Lab in the 3rd quarter worth approximately $391,000. Finally, Apollon Wealth Management LLC boosted its stake in shares of Rocket Lab by 38.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 15,109 shares of the rocket manufacturer’s stock valued at $1,053,000 after purchasing an additional 4,219 shares during the last quarter. Institutional investors own 71.78% of the company’s stock.

Rocket Lab Price Performance

Rocket Lab stock opened at $54.73 on Friday. The stock has a market capitalization of $32.75 billion, a price-to-earnings ratio of -202.70 and a beta of 2.93. Rocket Lab Corporation has a 52-week low of $37.57 and a 52-week high of $151.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The stock’s 50 day moving average price is $64.23 and its two-hundred day moving average price is $79.93.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The company had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. On average, equities analysts predict that Rocket Lab Corporation will post -0.20 earnings per share for the current year.

Insider Transactions at Rocket Lab

In other news, CFO Adam Spice sold 140,157 shares of the stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the transaction, the chief financial officer owned 1,155,967 shares of the company’s stock, valued at $81,865,582.94. This represents a 10.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 6,034 shares of the stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $66.65, for a total transaction of $402,166.10. Following the transaction, the senior vice president directly owned 250,917 shares in the company, valued at $16,723,618.05. This trade represents a 2.35% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is owned by insiders.

Rocket Lab News Roundup

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. KGI Securities upgraded shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 price objective for the company in a research report on Monday, July 27th. Piper Sandler began coverage on shares of Rocket Lab in a report on Wednesday, July 15th. They issued a “neutral” rating and a $83.00 target price on the stock. Wall Street Zen cut shares of Rocket Lab from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Citigroup reiterated a “market outperform” rating on shares of Rocket Lab in a report on Friday, October 16th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Three analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Rocket Lab presently has a consensus rating of “Moderate Buy” and a consensus target price of $102.05.

About Rocket Lab

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.